Dr. Peters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
330 Brookline Ave
Shapiro 913
Boston, MA 02215Phone+1 617-667-2100Fax+1 617-975-5665- Is this information wrong?
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2011 - 2014
- University of Massachusetts Medical SchoolClass of 2011
- Stanford UniversityMS, 1993 - 1995
- Massachusetts Institute of TechnologySB, Biology, French Literature, 1988 - 1992
Certifications & Licensure
- MA State Medical License 2014 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) Start of enrollment: 2020 Oct 16
Roles: Contact
- Futibatinib in Patients With Specific FGFR Aberrations Start of enrollment: 2020 Aug 24
Roles: Contact
Publications & Presentations
PubMed
- 15 citationsDuration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication.Peter P Mueller, Qiushi Chen, Turgay Ayer, Gizem S Nemutlu, Ali Hajjar, Emily D Bethea, Mary Linton B Peters, Brian P Lee, Naveed Z Janjua, Fasiha Kanwal, Jagpreet Chh...> ;Journal of Hepatology. 2022 Jul 1
- 1 citationsGenetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model.Mary Linton B Peters, Andrew Eckel, Anna Lietz, Claudia Seguin, Peter Mueller, Chin Hur, Pari V Pandharipande> ;Pancreatology. 2022 Sep 1
- 35 citationsOrganoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer., , , , , , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2021 Nov 17
- Join now to see all
Professional Memberships
- Member
- Member
- Society for Medical Decision MakingMember
- Society of Decision ProfessionalsFellow
- Member
- Member
- Member
Hospital Affiliations
- Beth Israel Deaconess Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: